• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成并鉴定五个无症状个体来源的新型人诱导多能干细胞 (iPSC) 系,这些个体携带有致病性 PLN-R14del 变异以及一个无该变异的亲缘个体。

Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant and a non-carrier relative.

机构信息

Department of Neurosciences, Psychology, Drugs and Child Health, University of Florence, Florence, Italy.

Department of Cardiology, Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

Stem Cell Res. 2023 Oct;72:103208. doi: 10.1016/j.scr.2023.103208. Epub 2023 Sep 21.

DOI:10.1016/j.scr.2023.103208
PMID:37748331
Abstract

The rare genetic alteration PLN-c.(40_42delAGA), leading to the deletion of arginine 14 (p.R14del) in phospholamban, is associated with dilated and arrhythmogenic cardiomyopathies occurring in early-adulthood. However, some carriers remain asymptomatic with normal lifespans. Here, we report human induced pluripotent stem cell (iPSC) lines generated from peripheral blood mononuclear cells (PBMCs) of five PLN-R14del carriers, who were asymptomatic at the time of blood collection, and one non-carrier family member. Each line exhibited typical iPSC morphology, pluripotency markers, and tri-lineage differentiation. These cell lines provide a valuable model to investigate the mechanisms underlying the onset, progression, and patient-specific resistance to PLN-R14del-induced cardiomyopathy.

摘要

PLN-c.(40_42delAGA) 这一罕见的基因突变导致磷蛋白磷酸酶结合蛋白第 14 位精氨酸缺失(p.R14del),与成年早期发生的扩张型和心律失常性心肌病有关。然而,一些携带者在血液采集时无症状,且寿命正常。在这里,我们报告了从五个 PLN-R14del 携带者的外周血单核细胞(PBMC)和一个非携带者的家族成员中生成的人诱导多能干细胞(iPSC)系。每个系均表现出典型的 iPSC 形态、多能性标记和三系分化。这些细胞系为研究 PLN-R14del 诱导的心肌病的发病机制、进展和患者特异性抵抗机制提供了有价值的模型。

相似文献

1
Generation and characterization of novel human induced pluripotent stem cell (iPSC) lines originating from five asymptomatic individuals carrying the PLN-R14del pathogenic variant and a non-carrier relative.生成并鉴定五个无症状个体来源的新型人诱导多能干细胞 (iPSC) 系,这些个体携带有致病性 PLN-R14del 变异以及一个无该变异的亲缘个体。
Stem Cell Res. 2023 Oct;72:103208. doi: 10.1016/j.scr.2023.103208. Epub 2023 Sep 21.
2
Generation of human induced pluripotent stem cell (iPSC) lines derived from five patients carrying the pathogenic phospholamban-R14del (PLN-R14del) variant and three non-carrier family members.源自五名携带致病性磷酸受纳蛋白-R14缺失(PLN-R14del)变体的患者和三名非携带者家庭成员的人类诱导多能干细胞(iPSC)系的生成。
Stem Cell Res. 2022 Apr;60:102737. doi: 10.1016/j.scr.2022.102737. Epub 2022 Mar 1.
3
Generation of human induced pluripotent stem cell lines carrying heterozygous PLN mutation from dilated cardiomyopathy patients.从扩张型心肌病患者中生成携带杂合 PLN 突变的人诱导多能干细胞系。
Stem Cell Res. 2022 Aug;63:102855. doi: 10.1016/j.scr.2022.102855. Epub 2022 Jul 11.
4
Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C.生成两个携带磷酸甘油酸变位酶 R14del 突变的诱导多能干细胞系,用于 ARVD/C 建模。
Stem Cell Res. 2022 Aug;63:102834. doi: 10.1016/j.scr.2022.102834. Epub 2022 Jun 6.
5
Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).莱杜克跨大西洋卓越研究网络,旨在治疗磷酸化兰尼碱受体引起的心肌病(CURE-PLaN)。
Circ Res. 2019 Sep 13;125(7):720-724. doi: 10.1161/CIRCRESAHA.119.315077. Epub 2019 Sep 12.
6
Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.未折叠蛋白反应作为 PLN R14del 心肌病的代偿机制和潜在治疗靶点。
Circulation. 2021 Aug 3;144(5):382-392. doi: 10.1161/CIRCULATIONAHA.120.049844. Epub 2021 Apr 30.
7
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.使用靶向核酸酶和联合疗法纠正与心肌病相关的人类磷酸受纳蛋白R14del突变。
Nat Commun. 2015 Apr 29;6:6955. doi: 10.1038/ncomms7955.
8
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.心律失常性磷蛋白兰巴因 R14del 人源化小鼠心室中动作电位调节剂同工型变化。
Metabolism. 2023 Jan;138:155344. doi: 10.1016/j.metabol.2022.155344. Epub 2022 Nov 12.
9
Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).从四名患有与成人发作性肥厚型心肌病(HCM)相关的致病性ALPK3变体的患者中获得人诱导多能干细胞系。
Stem Cell Res. 2023 Dec;73:103233. doi: 10.1016/j.scr.2023.103233. Epub 2023 Oct 26.
10
Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.磷酸调节蛋白 R14del 突变所致遗传性心肌病的人源化小鼠模型中心律失常的机制和动力学
Circulation. 2021 Aug 10;144(6):441-454. doi: 10.1161/CIRCULATIONAHA.119.043502. Epub 2021 May 24.

引用本文的文献

1
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models.在体方法理解致心律失常性心肌病:动物模型的观点。
Cells. 2024 Jul 27;13(15):1264. doi: 10.3390/cells13151264.